Good afternoon, gentlemen. I also want to express my thanks to Dr. Benn and Mr. Robinson for your years of service and good luck to Mr. Boule on your new responsibilities.
I want to start with a medical question. As you know, with AIDS, there is always this opportunity for opportunistic infections. Right now in Africa, we know there is a huge preponderance of schistosomiasis, which will accelerate the progression of HIV. Let's set aside malaria and TB for a second. You have HIV, which you are fully focused on and you're dealing with HIV. You have the cocktail ready and you're giving the medication. There might be others. I just used one example because of its high rate of preponderance.
What are you doing to tackle that also, when you know it's connected to HIV? Not only that, but I'm sure there are other partners there working in unison. Is there isolation or are you working together? If that problem isn't solved, would that opportunistic parasite...? There may be others that will impact how you would deal with HIV.